Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2243567528;67529;67530 chr2:178579984;178579983;178579982chr2:179444711;179444710;179444709
N2AB2079462605;62606;62607 chr2:178579984;178579983;178579982chr2:179444711;179444710;179444709
N2A1986759824;59825;59826 chr2:178579984;178579983;178579982chr2:179444711;179444710;179444709
N2B1337040333;40334;40335 chr2:178579984;178579983;178579982chr2:179444711;179444710;179444709
Novex-11349540708;40709;40710 chr2:178579984;178579983;178579982chr2:179444711;179444710;179444709
Novex-21356240909;40910;40911 chr2:178579984;178579983;178579982chr2:179444711;179444710;179444709
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Fn3-50
  • Domain position: 82
  • Structural Position: 115
  • Q(SASA): 0.1846
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/V None None 1.0 D 0.887 0.7 0.723402577445 gnomAD-4.0.0 1.59243E-06 None None None None I None 0 0 None 0 0 None 0 0 2.86025E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.9564 likely_pathogenic 0.9604 pathogenic -0.724 Destabilizing 1.0 D 0.758 deleterious D 0.574146462 None None I
G/C 0.9794 likely_pathogenic 0.9855 pathogenic -1.06 Destabilizing 1.0 D 0.874 deleterious D 0.57541391 None None I
G/D 0.9891 likely_pathogenic 0.992 pathogenic -1.09 Destabilizing 1.0 D 0.915 deleterious D 0.542813024 None None I
G/E 0.9939 likely_pathogenic 0.9952 pathogenic -1.218 Destabilizing 1.0 D 0.906 deleterious None None None None I
G/F 0.9976 likely_pathogenic 0.9979 pathogenic -1.217 Destabilizing 1.0 D 0.895 deleterious None None None None I
G/H 0.9962 likely_pathogenic 0.9972 pathogenic -1.001 Destabilizing 1.0 D 0.871 deleterious None None None None I
G/I 0.9973 likely_pathogenic 0.9976 pathogenic -0.662 Destabilizing 1.0 D 0.898 deleterious None None None None I
G/K 0.9957 likely_pathogenic 0.9966 pathogenic -1.263 Destabilizing 1.0 D 0.905 deleterious None None None None I
G/L 0.9958 likely_pathogenic 0.9964 pathogenic -0.662 Destabilizing 1.0 D 0.875 deleterious None None None None I
G/M 0.9982 likely_pathogenic 0.9984 pathogenic -0.571 Destabilizing 1.0 D 0.873 deleterious None None None None I
G/N 0.9919 likely_pathogenic 0.9929 pathogenic -0.934 Destabilizing 1.0 D 0.852 deleterious None None None None I
G/P 0.9996 likely_pathogenic 0.9997 pathogenic -0.646 Destabilizing 1.0 D 0.906 deleterious None None None None I
G/Q 0.9923 likely_pathogenic 0.9935 pathogenic -1.231 Destabilizing 1.0 D 0.915 deleterious None None None None I
G/R 0.9849 likely_pathogenic 0.9883 pathogenic -0.755 Destabilizing 1.0 D 0.917 deleterious D 0.563132552 None None I
G/S 0.9167 likely_pathogenic 0.9321 pathogenic -1.115 Destabilizing 1.0 D 0.853 deleterious D 0.547394927 None None I
G/T 0.9888 likely_pathogenic 0.9908 pathogenic -1.179 Destabilizing 1.0 D 0.904 deleterious None None None None I
G/V 0.9948 likely_pathogenic 0.9953 pathogenic -0.646 Destabilizing 1.0 D 0.887 deleterious D 0.562625572 None None I
G/W 0.9958 likely_pathogenic 0.9974 pathogenic -1.394 Destabilizing 1.0 D 0.881 deleterious None None None None I
G/Y 0.9964 likely_pathogenic 0.9971 pathogenic -1.07 Destabilizing 1.0 D 0.895 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.